Skip to main content
. 2023 Aug 21;16:167. doi: 10.1186/s13048-023-01251-w

Table 2.

Comparison of screening markers in the PCOS and control groups

Variables PCOS (n = 90) Control (n = 90) P-value
NT (mm)* 1.6 ± 0.38 1.41 ± 0.36 0.37
Free β-HCG (ng/ml)* 34.42 ± 18.92 28.99 ± 18.80 0.04
PAPP-A (mu/ml)* 4903.80 ± 8571.87 2994.93 ± 1626.76 0.59
AFP (ng/ml)** 38.34 ± 15.91 32.14 ± 15.13 0.02
HCG (mu/ml)* 19496.31 ± 16694.98 177199.21 ± 18877.56 0.11
UE3 (ng/ml)* 2.3 ± 1.89 2.01 ± 1.12 0.45
Inhibin-A (pg/ml)* 276.14 ± 129.38 223.44 ± 102.07 0.001

PCOS: Polycystic Ovary Syndrome, NT: Nuchal Translucency, Free β-HCG: Free Beta-Human Chorionic Gonadotropin, PAPP-A: Plasma Protein A, AFP: Alpha Fetoprotein, HCG: Human Chorionic Gonadotropin, UE3: Unconjugated Estriol

*Values are given as mean ± SD using Mann-Whitney’s U test

**Values are given as mean ± SD using students T-test